Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022049811> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W2022049811 abstract "CHF5074 is a new g-secretase modulator that preferentially inhibits b-amyloid1-42 (Ab42) secretion at low micromolar concentrations. Long-term administration of CHF5074 to transgenic mice carrying the Swedish mutation of human amyloid precursor protein (APPswe) has been shown to robustly reduce brain plaque area fraction in both cortex and hippocampus (JPET 2007; 323: 822-30). The present study was carried out to assess the effects of CHF5074 on primary neuronal cultures, obtained from brain of APPswe transgenic mice and to identify the potential mechanisms involved. Neuronal cortical-hippocampal cultures were obtained employing embryos of APPswe transgenic mice. Briefly, hippocampi and frontal cortices were dissected from embryonic-day 16-18 (E16-18) mice obtained by breeding female B6SJLF1 mice with hemizygous male transgenic mice. The tissue was mechanically dissociated by pipetting in DMEM (Dulbecco's modified Eagle's medium) containing 2 mM L-glutamine and 10% fetal calf serum. Cells were plated overnight on poly-(l-lysine)-coated 24 well plates and maintained at 37°C in humidified 95% air and 5% CO2. After 24 hours, culture medium was substituted with DMEM containing B27 and 2 mM L-glutamine. Experiments with CHF5074 were performed at day 8 in vitro in DMEM supplemented with N-2 (GIBCO). Ab released in the medium was determined by peptide-specific ELISA (Genetics Co.). Total RNA was extracted with Trizol and neurotrophin expression evaluated by semi-quantitative RT-PCR. We found that CHF5074, selectively and dose-dependently decreases Ab42 levels in culture media of primary cortical neurons. The IC50 for inhibition of Ab42 and Ab40 was 5.3 and 54 mM, respectively. Treatment did not result in any significant effect on cell viability. The Ab42-lowering action of CHF5074 was accompanied by a 2-fold up-regulation of nerve growth factor transcription after 48 hour treatments. These findings suggest that increased neurotrophic support might, in addition to gósecretase modulation, represent an underlying mechanism contributing to the beneficial effects of CHF-5074 seen in AD animal models." @default.
- W2022049811 created "2016-06-24" @default.
- W2022049811 creator A5012686617 @default.
- W2022049811 creator A5022764193 @default.
- W2022049811 creator A5033175887 @default.
- W2022049811 creator A5045108395 @default.
- W2022049811 creator A5049395883 @default.
- W2022049811 creator A5082467149 @default.
- W2022049811 date "2009-07-01" @default.
- W2022049811 modified "2023-09-27" @default.
- W2022049811 title "P3-278: CHF5074, a new g-secretase modulator, stimulates neurotrophin expression in primary neurons" @default.
- W2022049811 doi "https://doi.org/10.1016/j.jalz.2009.04.949" @default.
- W2022049811 hasPublicationYear "2009" @default.
- W2022049811 type Work @default.
- W2022049811 sameAs 2022049811 @default.
- W2022049811 citedByCount "0" @default.
- W2022049811 crossrefType "journal-article" @default.
- W2022049811 hasAuthorship W2022049811A5012686617 @default.
- W2022049811 hasAuthorship W2022049811A5022764193 @default.
- W2022049811 hasAuthorship W2022049811A5033175887 @default.
- W2022049811 hasAuthorship W2022049811A5045108395 @default.
- W2022049811 hasAuthorship W2022049811A5049395883 @default.
- W2022049811 hasAuthorship W2022049811A5082467149 @default.
- W2022049811 hasConcept C102230213 @default.
- W2022049811 hasConcept C104317684 @default.
- W2022049811 hasConcept C134018914 @default.
- W2022049811 hasConcept C136834591 @default.
- W2022049811 hasConcept C141035611 @default.
- W2022049811 hasConcept C148762608 @default.
- W2022049811 hasConcept C153911025 @default.
- W2022049811 hasConcept C185592680 @default.
- W2022049811 hasConcept C2777738006 @default.
- W2022049811 hasConcept C2781161787 @default.
- W2022049811 hasConcept C28328180 @default.
- W2022049811 hasConcept C55493867 @default.
- W2022049811 hasConcept C86803240 @default.
- W2022049811 hasConcept C95444343 @default.
- W2022049811 hasConceptScore W2022049811C102230213 @default.
- W2022049811 hasConceptScore W2022049811C104317684 @default.
- W2022049811 hasConceptScore W2022049811C134018914 @default.
- W2022049811 hasConceptScore W2022049811C136834591 @default.
- W2022049811 hasConceptScore W2022049811C141035611 @default.
- W2022049811 hasConceptScore W2022049811C148762608 @default.
- W2022049811 hasConceptScore W2022049811C153911025 @default.
- W2022049811 hasConceptScore W2022049811C185592680 @default.
- W2022049811 hasConceptScore W2022049811C2777738006 @default.
- W2022049811 hasConceptScore W2022049811C2781161787 @default.
- W2022049811 hasConceptScore W2022049811C28328180 @default.
- W2022049811 hasConceptScore W2022049811C55493867 @default.
- W2022049811 hasConceptScore W2022049811C86803240 @default.
- W2022049811 hasConceptScore W2022049811C95444343 @default.
- W2022049811 hasIssue "4S_Part_14" @default.
- W2022049811 hasLocation W20220498111 @default.
- W2022049811 hasOpenAccess W2022049811 @default.
- W2022049811 hasPrimaryLocation W20220498111 @default.
- W2022049811 hasRelatedWork W1968701523 @default.
- W2022049811 hasRelatedWork W1985878253 @default.
- W2022049811 hasRelatedWork W2003704824 @default.
- W2022049811 hasRelatedWork W2019358971 @default.
- W2022049811 hasRelatedWork W2035266346 @default.
- W2022049811 hasRelatedWork W2046024114 @default.
- W2022049811 hasRelatedWork W2062031492 @default.
- W2022049811 hasRelatedWork W2379719180 @default.
- W2022049811 hasRelatedWork W2793490535 @default.
- W2022049811 hasRelatedWork W3089718183 @default.
- W2022049811 hasVolume "5" @default.
- W2022049811 isParatext "false" @default.
- W2022049811 isRetracted "false" @default.
- W2022049811 magId "2022049811" @default.
- W2022049811 workType "article" @default.